NAP Molecular Neuroendocrinology Research Group, Institute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Institute, University of Pécs, 7624 Pécs, Hungary.
BioTalentum Ltd., 2100 Gödöllő, Hungary.
Int J Mol Sci. 2021 Dec 9;22(24):13260. doi: 10.3390/ijms222413260.
Neurotrophin receptors such as the tropomyosin receptor kinase A receptor (TrkA) and the low-affinity binding p75 neurotrophin receptor p75 play a critical role in neuronal survival and their functions are altered in Alzheimer's disease (AD). Changes in the dynamics of receptors on the plasma membrane are essential to receptor function. However, whether receptor dynamics are affected in different pathophysiological conditions is unexplored. Using live-cell single-molecule imaging, we examined the surface trafficking of TrkA and p75 molecules on live neurons that were derived from human-induced pluripotent stem cells (hiPSCs) of mutant familial AD (fAD) patients and non-demented control subjects. Our results show that the surface movement of TrkA and p75 and the activation of TrkA- and p75-related phosphoinositide-3-kinase (PI3K)/serine/threonine-protein kinase (AKT) signaling pathways are altered in neurons that are derived from patients suffering from fAD compared to controls. These results provide evidence for altered surface movement of receptors in AD and highlight the importance of investigating receptor dynamics in disease conditions. Uncovering these mechanisms might enable novel therapies for AD.
神经生长因子受体,如原肌球蛋白受体激酶 A 受体(TrkA)和低亲和力结合 p75 神经营养因子受体 p75,在神经元存活中发挥着关键作用,其功能在阿尔茨海默病(AD)中发生改变。质膜上受体的动力学变化对于受体功能至关重要。然而,在不同的病理生理条件下,受体动力学是否受到影响尚不清楚。使用活细胞单分子成像,我们检测了源自突变家族性 AD(fAD)患者和非痴呆对照的人类诱导多能干细胞(hiPSC)的原代神经元上 TrkA 和 p75 分子的表面转运。我们的结果表明,与对照组相比,源自 fAD 患者的神经元中 TrkA 和 p75 的表面运动以及 TrkA 和 p75 相关的磷酸肌醇-3-激酶(PI3K)/丝氨酸/苏氨酸蛋白激酶(AKT)信号通路的激活发生改变。这些结果为 AD 中受体表面运动的改变提供了证据,并强调了在疾病条件下研究受体动力学的重要性。揭示这些机制可能为 AD 提供新的治疗方法。